These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 9341930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
    Hanemann CO, Gabreëls-Fasten AA, Müller HW, Stoll G.
    Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PMP22 expression in dermal nerve myelin from patients with CMT1A.
    Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J.
    Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
    [Abstract] [Full Text] [Related]

  • 8. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease.
    Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, Lützelschwab R, Steck AJ, Pareyson D, Peles E, Schaeren-Wiemers N.
    Neurobiol Dis; 2013 Jan; 49():221-31. PubMed ID: 22940629
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
    Hanemann CO, Müller HW.
    Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S, Scherer SS, Nave KA, Suter U.
    J Neurosci Res; 2002 Feb 15; 67(4):443-9. PubMed ID: 11835311
    [Abstract] [Full Text] [Related]

  • 13. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S, Young P, Suter U.
    Brain; 2001 Nov 15; 124(Pt 11):2177-87. PubMed ID: 11673320
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G, Visigalli D, Prukop T, Cervellini I, Mannino E, Venturi C, Bruzzone S, Sereda MW, Schenone A.
    Neurobiol Dis; 2016 Nov 15; 95():145-57. PubMed ID: 27431093
    [Abstract] [Full Text] [Related]

  • 18. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A.
    Hanemann CO, D'Urso D, Gabreëls-Festen AA, Müller HW.
    Brain; 2000 May 15; 123 ( Pt 5)():1001-6. PubMed ID: 10775544
    [Abstract] [Full Text] [Related]

  • 19. Dosage effects of PMP22 on nonmyelinating Schwann cells in hereditary neuropathy with liability to pressure palsies.
    Koike H, Furukawa S, Mouri N, Fukami Y, Iijima M, Katsuno M.
    Neuromuscul Disord; 2022 Jun 15; 32(6):503-511. PubMed ID: 35501275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.